{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:30:35Z","timestamp":1768879835338,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T00:00:00Z","timestamp":1588464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.cmi.2020.04.041","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:12:37Z","timestamp":1588720357000},"page":"269-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study"],"prefix":"10.1016","volume":"27","author":[{"given":"J.W. Timot\u00ebus","family":"Deelen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.C.","family":"Rottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.M.","family":"Buiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.","family":"Dorigo-Zetsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.J.W.","family":"Kluytmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.F.T.","family":"Thijsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.M.","family":"Vlaminckx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.L.","family":"Weersink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.S.M.","family":"Ammerlaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.M.","family":"Bonten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"van Werkhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.04.041_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003344.pub3","article-title":"Cochrane Database of Systematic Reviews \u03b2-lactam antibiotic monotherapy versus \u03b2-lactam- aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2020.04.041_bib2","volume":"vol. 43","author":"Rhodes","year":"2016"},{"key":"10.1016\/j.cmi.2020.04.041_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00365548.2012.747694","article-title":"Rational use of aminoglycosides-review and recommendations by the Swedish reference group for antibiotics (SRGA)","volume":"45","author":"Hanberger","year":"2013","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.cmi.2020.04.041_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.medmal.2011.07.007","article-title":"Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring","volume":"42","year":"2012","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.cmi.2020.04.041_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/cid\/cix186","article-title":"Short-course adjunctive gentamicin as empirical therapy in patients with severe sepsis and septic shock\u202f: a prospective observational cohort study","volume":"64","author":"Ong","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2020.04.041_bib6","first-page":"1","article-title":"CDC\/NHSN surveillance definitions for specific types of infections","volume":"2015","year":"2016","journal-title":"Surveill Defin"},{"key":"10.1016\/j.cmi.2020.04.041_bib7","author":"Long"},{"key":"10.1016\/j.cmi.2020.04.041_bib8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/EDE.0b013e3181577654","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"18","author":"Von Elm","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.cmi.2020.04.041_bib9","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1128\/AAC.03750-14","article-title":"Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shock","volume":"58","author":"Picard","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.04.041_bib10","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/23744235.2015.1109136","article-title":"No increased risk of acute kidney injury after a single dose of gentamicin in patients with sepsis","volume":"48","author":"Cobussen","year":"2016","journal-title":"Infect Dis (Auckl)"},{"key":"10.1016\/j.cmi.2020.04.041_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/clinids\/4.2.237","article-title":"Bactericidal synergism between \u03b2-lactams and aminoglycosides: mechanism and possible therapeutic implications","volume":"4","author":"Davis","year":"1982","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.cmi.2020.04.041_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.cmi.2015.10.034","article-title":"Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals","volume":"22","author":"Fitzpatrick","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2020.04.041_bib13","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.01523-12","article-title":"Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-\u03b2-lactamase-producing bacteria","volume":"57","author":"Frakking","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.04.041_bib14","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1007\/s12325-017-0622-8","article-title":"Sepsis: a review of advances in management","volume":"34","author":"Rello","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.cmi.2020.04.041_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/CMR.00059-12","article-title":"Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?","volume":"26","author":"Beceiro","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cmi.2020.04.041_bib16","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/AAC.04819-14","article-title":"Amdinocillin (mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli","volume":"59","author":"Thulin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2020.04.041_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0166527","article-title":"14-year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity\u2014an independent risk factor for both BSI and mortality","volume":"11","author":"Holmbom","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2020.04.041_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s15010-019-01277-7","article-title":"Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection","author":"Battle","year":"2019","journal-title":"Infection"},{"key":"10.1016\/j.cmi.2020.04.041_bib19","first-page":"443","article-title":"Gentamicin is frequently underdosed in patients with sepsis in the emergency department","volume":"73","author":"Cobussen","year":"2015","journal-title":"Neth J Med"},{"key":"10.1016\/j.cmi.2020.04.041_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","article-title":"Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration","volume":"155","author":"Moore","year":"1987","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.04.041_bib21","series-title":"SWAB guidelines for Antibacterial therapy of adult patients with Sepsis. Amsterdam","year":"2010"},{"key":"10.1016\/j.cmi.2020.04.041_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmi.2017.09.020","article-title":"Is a randomized trial of a short course of aminoglycoside added to \u03b2-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?","volume":"24","author":"Ong","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2030269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2030269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:27:46Z","timestamp":1761118066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2030269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S1198743X2030269X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.04.041","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-course aminoglycosides as adjunctive empirical therapy in patients with Gram-negative bloodstream infection, a cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}